TCL Archive New Opportunities Still Abound In Immunology Program, Terry and other NCI Executives Say February 27, 1976
TCL Archive IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies May 8, 1987
TCL Archive NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA. July 13, 2007